Lemaitre Vascular (LMAT) Misses Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $87.92 +9.08%
Financial Fact:
General and administrative: 3.6M
Today's EPS Names:
CIX, ARIS, COHR, More
Financial Fact:
General and administrative: 3.6M
Today's EPS Names:
CIX, ARIS, COHR, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.30, $0.02 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $38.4 million versus the consensus estimate of $39.05 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viemed Healthcare, Inc. (VMD) Misses Q3 EPS by 2c; updates guidance
- FatPipe, Inc. (FATN) Reports Q3 EPS of $0.09
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
